Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 2 |
GO:0005815 | microtubule organizing center | 2 | 2 |
GO:0036064 | ciliary basal body | 3 | 2 |
GO:0097542 | ciliary tip | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4Q2P3
Term | Name | Level | Count |
---|---|---|---|
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0006996 | organelle organization | 4 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0016043 | cellular component organization | 3 | 2 |
GO:0018095 | protein polyglutamylation | 7 | 2 |
GO:0018193 | peptidyl-amino acid modification | 5 | 2 |
GO:0018200 | peptidyl-glutamic acid modification | 6 | 2 |
GO:0019538 | protein metabolic process | 3 | 2 |
GO:0022607 | cellular component assembly | 4 | 2 |
GO:0030030 | cell projection organization | 4 | 2 |
GO:0030031 | cell projection assembly | 5 | 2 |
GO:0036211 | protein modification process | 4 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 2 |
GO:0043412 | macromolecule modification | 4 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0044782 | cilium organization | 5 | 2 |
GO:0060271 | cilium assembly | 6 | 2 |
GO:0070925 | organelle assembly | 5 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:0071840 | cellular component organization or biogenesis | 2 | 2 |
GO:0120031 | plasma membrane bounded cell projection assembly | 6 | 2 |
GO:0120036 | plasma membrane bounded cell projection organization | 5 | 2 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 15 | 17 | PF00675 | 0.441 |
CLV_NRD_NRD_1 | 213 | 215 | PF00675 | 0.603 |
CLV_NRD_NRD_1 | 244 | 246 | PF00675 | 0.574 |
CLV_PCSK_FUR_1 | 210 | 214 | PF00082 | 0.532 |
CLV_PCSK_KEX2_1 | 121 | 123 | PF00082 | 0.187 |
CLV_PCSK_KEX2_1 | 15 | 17 | PF00082 | 0.459 |
CLV_PCSK_KEX2_1 | 212 | 214 | PF00082 | 0.481 |
CLV_PCSK_KEX2_1 | 50 | 52 | PF00082 | 0.541 |
CLV_PCSK_PC1ET2_1 | 121 | 123 | PF00082 | 0.187 |
CLV_PCSK_PC1ET2_1 | 212 | 214 | PF00082 | 0.446 |
CLV_PCSK_PC1ET2_1 | 50 | 52 | PF00082 | 0.499 |
CLV_PCSK_SKI1_1 | 10 | 14 | PF00082 | 0.499 |
CLV_PCSK_SKI1_1 | 121 | 125 | PF00082 | 0.257 |
CLV_PCSK_SKI1_1 | 43 | 47 | PF00082 | 0.509 |
CLV_PCSK_SKI1_1 | 75 | 79 | PF00082 | 0.550 |
CLV_PCSK_SKI1_1 | 99 | 103 | PF00082 | 0.352 |
DEG_APCC_KENBOX_2 | 147 | 151 | PF00400 | 0.430 |
DOC_MAPK_gen_1 | 146 | 155 | PF00069 | 0.417 |
DOC_MAPK_MEF2A_6 | 122 | 131 | PF00069 | 0.368 |
DOC_MAPK_RevD_3 | 1 | 16 | PF00069 | 0.578 |
DOC_PP2B_PxIxI_1 | 126 | 132 | PF00149 | 0.420 |
DOC_PP4_FxxP_1 | 83 | 86 | PF00568 | 0.473 |
DOC_USP7_MATH_1 | 100 | 104 | PF00917 | 0.298 |
DOC_USP7_MATH_1 | 225 | 229 | PF00917 | 0.543 |
DOC_USP7_MATH_1 | 241 | 245 | PF00917 | 0.596 |
DOC_USP7_UBL2_3 | 46 | 50 | PF12436 | 0.501 |
LIG_14-3-3_CanoR_1 | 15 | 23 | PF00244 | 0.499 |
LIG_14-3-3_CanoR_1 | 226 | 236 | PF00244 | 0.511 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.482 |
LIG_EH_1 | 135 | 139 | PF12763 | 0.473 |
LIG_FHA_1 | 100 | 106 | PF00498 | 0.252 |
LIG_FHA_1 | 33 | 39 | PF00498 | 0.408 |
LIG_LIR_Apic_2 | 80 | 86 | PF02991 | 0.476 |
LIG_LIR_Apic_2 | 88 | 93 | PF02991 | 0.458 |
LIG_LIR_Gen_1 | 102 | 112 | PF02991 | 0.288 |
LIG_LIR_Gen_1 | 149 | 158 | PF02991 | 0.520 |
LIG_LIR_Gen_1 | 191 | 200 | PF02991 | 0.380 |
LIG_LIR_Gen_1 | 55 | 65 | PF02991 | 0.341 |
LIG_LIR_Nem_3 | 102 | 107 | PF02991 | 0.288 |
LIG_LIR_Nem_3 | 149 | 155 | PF02991 | 0.500 |
LIG_LIR_Nem_3 | 191 | 195 | PF02991 | 0.397 |
LIG_LIR_Nem_3 | 55 | 60 | PF02991 | 0.345 |
LIG_LYPXL_yS_3 | 126 | 129 | PF13949 | 0.471 |
LIG_PTB_Apo_2 | 165 | 172 | PF02174 | 0.498 |
LIG_PTB_Apo_2 | 17 | 24 | PF02174 | 0.495 |
LIG_PTB_Phospho_1 | 165 | 171 | PF10480 | 0.368 |
LIG_PTB_Phospho_1 | 17 | 23 | PF10480 | 0.494 |
LIG_Rb_LxCxE_1 | 102 | 116 | PF01857 | 0.300 |
LIG_SH2_CRK | 23 | 27 | PF00017 | 0.567 |
LIG_SH2_GRB2like | 192 | 195 | PF00017 | 0.309 |
LIG_SH2_NCK_1 | 23 | 27 | PF00017 | 0.439 |
LIG_SH2_PTP2 | 152 | 155 | PF00017 | 0.488 |
LIG_SH2_STAP1 | 192 | 196 | PF00017 | 0.364 |
LIG_SH2_STAT5 | 104 | 107 | PF00017 | 0.417 |
LIG_SH2_STAT5 | 152 | 155 | PF00017 | 0.464 |
LIG_SH3_3 | 134 | 140 | PF00018 | 0.417 |
LIG_SH3_3 | 197 | 203 | PF00018 | 0.399 |
LIG_SUMO_SIM_anti_2 | 176 | 182 | PF11976 | 0.417 |
LIG_TRAF2_1 | 70 | 73 | PF00917 | 0.403 |
LIG_TYR_ITIM | 124 | 129 | PF00017 | 0.511 |
LIG_TYR_ITSM | 100 | 107 | PF00017 | 0.209 |
MOD_CK1_1 | 32 | 38 | PF00069 | 0.477 |
MOD_CK2_1 | 67 | 73 | PF00069 | 0.503 |
MOD_GlcNHglycan | 17 | 20 | PF01048 | 0.576 |
MOD_GlcNHglycan | 31 | 34 | PF01048 | 0.460 |
MOD_GSK3_1 | 216 | 223 | PF00069 | 0.470 |
MOD_GSK3_1 | 236 | 243 | PF00069 | 0.599 |
MOD_NEK2_1 | 166 | 171 | PF00069 | 0.540 |
MOD_NEK2_1 | 236 | 241 | PF00069 | 0.509 |
MOD_PIKK_1 | 216 | 222 | PF00454 | 0.525 |
MOD_PKA_1 | 15 | 21 | PF00069 | 0.563 |
MOD_PKA_2 | 14 | 20 | PF00069 | 0.602 |
MOD_PKA_2 | 225 | 231 | PF00069 | 0.626 |
MOD_PKA_2 | 241 | 247 | PF00069 | 0.597 |
MOD_Plk_2-3 | 73 | 79 | PF00069 | 0.519 |
MOD_Plk_4 | 100 | 106 | PF00069 | 0.209 |
MOD_Plk_4 | 166 | 172 | PF00069 | 0.450 |
MOD_Plk_4 | 73 | 79 | PF00069 | 0.519 |
MOD_SUMO_rev_2 | 70 | 77 | PF00179 | 0.485 |
TRG_ENDOCYTIC_2 | 104 | 107 | PF00928 | 0.417 |
TRG_ENDOCYTIC_2 | 126 | 129 | PF00928 | 0.511 |
TRG_ENDOCYTIC_2 | 152 | 155 | PF00928 | 0.521 |
TRG_ENDOCYTIC_2 | 192 | 195 | PF00928 | 0.350 |
TRG_ENDOCYTIC_2 | 23 | 26 | PF00928 | 0.446 |
TRG_ER_diArg_1 | 59 | 62 | PF00400 | 0.340 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P5F3 | Leptomonas seymouri | 68% | 100% |
A0A1X0PB71 | Trypanosomatidae | 47% | 100% |
A0A3S7X866 | Leishmania donovani | 94% | 100% |
A0A422N4N2 | Trypanosoma rangeli | 50% | 99% |
A4HB20 | Leishmania braziliensis | 84% | 100% |
A4IA77 | Leishmania infantum | 93% | 100% |
C9ZM32 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 51% | 100% |
E9B590 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
Q9BYV8 | Homo sapiens | 25% | 67% |
V5BQF3 | Trypanosoma cruzi | 53% | 100% |